24.11 USD
▲+0.15+6.31%
盘后 22.69 +0.04%
2026-08-03
市值
$806.08M
市盈率
—
EPS
-6.75
股息率
—
52 周区间
17.06 – 32.44
成交量
93.54K
Beta
—
目标价
45.00
52W 低 17.0652W 高 32.44
价格走势
公司简介
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was...